Acute intoxication with diisopyramide: clinical and experimental study by hemoperfusion an Amberlite XAD 4 resin
- PMID: 7449357
- DOI: 10.3109/15563658008989994
Acute intoxication with diisopyramide: clinical and experimental study by hemoperfusion an Amberlite XAD 4 resin
Abstract
Diisopyramide overdose induces an early and severe cardiogenic shock; hemoperfusion on resin (Amberlite XAD 4) is the most efficient treatment. In vitro, 92% of the drug is adsorbed in 240 min. In dog, the plasmatic epuration is 66% with a mean plasma clearance of 74% plasmatic flow. A woman who had absorbed 4.50 g diisopyramide showed an idioventricular rhythm. The cardiac electrical stimulation and positive inotrope drugs were inefficient. Hemoperfusion on resin Amberlite XAD 4 corrected hemodynamic and ECG disturbances in 4 h. The epuration was proved by the decrease of diisopyramide plasma level: 24.4 micrograms/mL before epuration, 1.9 micrograms/mL after epuration, and a mean plasma clearance of 107.8 mL/min (61% of the plasmatic flow). Hemoperfusion of resin (Amberlite XAD 4) is more efficient than hemodialysis (cuprophan) and hemofiltration (polyacrylonitrile). The system that we have used is well tolerated and of low cost.
Similar articles
-
[Disopyramide poisoning].Schweiz Med Wochenschr. 1981 May 9;111(19):681-3. Schweiz Med Wochenschr. 1981. PMID: 7015494 Review. German.
-
Massive digitoxin intoxication. Treatment of Amberlite XAD 4 resin hemoperfusion.J Toxicol Clin Toxicol. 1982 Nov;19(9):931-50. doi: 10.3109/15563658208992526. J Toxicol Clin Toxicol. 1982. PMID: 7182522
-
[The effect of hemoperfusion with XAD-4 resin on biological constituents of the blood].Z Urol Nephrol. 1982 Jan;75(1):35-41. Z Urol Nephrol. 1982. PMID: 7064591 German.
-
Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin.Artif Organs. 1979 May;3(2):124-6. doi: 10.1111/j.1525-1594.1979.tb01023.x. Artif Organs. 1979. PMID: 533394
-
Acute toxicity of pyrazolones.Am J Med. 1983 Nov 14;75(5A):94-8. doi: 10.1016/0002-9343(83)90238-3. Am J Med. 1983. PMID: 6359872 Review.
Cited by
-
Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.Drugs. 1987 Aug;34(2):151-87. doi: 10.2165/00003495-198734020-00001. Drugs. 1987. PMID: 3304965 Review.
-
Clinical toxicology.Postgrad Med J. 1993 Jan;69(807):19-32. doi: 10.1136/pgmj.69.807.19. Postgrad Med J. 1993. PMID: 8095332 Free PMC article. Review. No abstract available.
-
Clinical pharmacokinetics of disopyramide.Clin Pharmacokinet. 1986 May-Jun;11(3):214-22. doi: 10.2165/00003088-198611030-00003. Clin Pharmacokinet. 1986. PMID: 3524956 Review.
-
Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.Drug Saf. 1990 Nov-Dec;5(6):393-420. doi: 10.2165/00002018-199005060-00002. Drug Saf. 1990. PMID: 2285495 Review.